Eli Lilly & Co.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 1.05%53.020.9%$1379.11m
JNJJohnson & Johnson 1.24%179.180.7%$1369.38m
BMYBristol-Myers Squibb Co. 0.87%76.861.0%$1207.80m
MRKMerck & Co., Inc. 0.62%94.130.7%$1146.72m
ABBVAbbVie, Inc. -1.13%149.301.9%$1125.23m
LLYEli Lilly & Co. 1.01%301.881.1%$901.26m
AZNAstraZeneca Plc 0.56%66.581.0%$520.54m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.18%143.700.0%$463.89m
VERUVeru, Inc. -0.37%13.330.0%$317.47m
NVSNovartis AG 1.47%90.730.2%$254.88m
GSKGlaxoSmithKline Plc 0.67%44.820.2%$244.80m
HZNPHorizon Therapeutics Plc -2.29%88.285.4%$195.81m
NVONovo Nordisk A/S 0.15%107.910.1%$191.01m
SGENSeagen Inc. 0.10%139.785.7%$181.93m
VTRSViatris, Inc. -1.27%11.650.0%$164.02m

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.